Krowka MJ - Search Results

1

Plasma levels of S100A4 in portopulmonary hypertension.

Peng T, Zamanian R, Krowka MJ, Benza RL, Roberts KE, Taichman DB, Rybak D, Trotter JF, Brown RS Jr, Fallon MB, Kawut SM; Pulmonary Vascular Complications of Liver Disease Study Group. Peng T, et al. Among authors: krowka mj. Biomarkers. 2009 May;14(3):156-60. doi: 10.1080/13547500902773896. Biomarkers. 2009. PMID: 19399660 Free PMC article.

2

Intrapulmonary vascular dilatations (IPVD) in liver transplant candidates. Screening by two-dimensional contrast-enhanced echocardiography.

Krowka MJ, Tajik AJ, Dickson ER, Wiesner RH, Cortese DA. Krowka MJ, et al. Chest. 1990 May;97(5):1165-70. doi: 10.1378/chest.97.5.1165. Chest. 1990. PMID: 2331913

3

Improvement in pulmonary hemodynamics during intravenous epoprostenol (prostacyclin): A study of 15 patients with moderate to severe portopulmonary hypertension.

Krowka MJ, Frantz RP, McGoon MD, Severson C, Plevak DJ, Wiesner RH. Krowka MJ, et al. Hepatology. 1999 Sep;30(3):641-8. doi: 10.1002/hep.510300307. Hepatology. 1999. PMID: 10462369

4

Pulmonary hemodynamics and perioperative cardiopulmonary-related mortality in patients with portopulmonary hypertension undergoing liver transplantation.

Krowka MJ, Plevak DJ, Findlay JY, Rosen CB, Wiesner RH, Krom RA. Krowka MJ, et al. Liver Transpl. 2000 Jul;6(4):443-50. doi: 10.1053/jlts.2000.6356. Liver Transpl. 2000. PMID: 10915166 Free article.

5

Accuracy of Doppler echocardiography in the assessment of pulmonary hypertension in liver transplant candidates.

Kim WR, Krowka MJ, Plevak DJ, Lee J, Rettke SR, Frantz RP, Wiesner RH. Kim WR, et al. Among authors: krowka mj. Liver Transpl. 2000 Jul;6(4):453-8. doi: 10.1053/jlts.2000.7573. Liver Transpl. 2000. PMID: 10915168 Free article.

6

Prospective evaluation of outcomes and predictors of mortality in patients with hepatopulmonary syndrome undergoing liver transplantation.

Arguedas MR, Abrams GA, Krowka MJ, Fallon MB. Arguedas MR, et al. Among authors: krowka mj. Hepatology. 2003 Jan;37(1):192-7. doi: 10.1053/jhep.2003.50023. Hepatology. 2003. PMID: 12500204

7

Hepatopulmonary syndrome and portopulmonary hypertension: a report of the multicenter liver transplant database.

Krowka MJ, Mandell MS, Ramsay MA, Kawut SM, Fallon MB, Manzarbeitia C, Pardo M Jr, Marotta P, Uemoto S, Stoffel MP, Benson JT. Krowka MJ, et al. Liver Transpl. 2004 Feb;10(2):174-82. doi: 10.1002/lt.20016. Liver Transpl. 2004. PMID: 14762853 Free article.

8

Natural history of hepatopulmonary syndrome: Impact of liver transplantation.

Swanson KL, Wiesner RH, Krowka MJ. Swanson KL, et al. Among authors: krowka mj. Hepatology. 2005 May;41(5):1122-9. doi: 10.1002/hep.20658. Hepatology. 2005. PMID: 15828054

9

Model for end-stage liver disease (MELD) exception for hepatopulmonary syndrome.

Fallon MB, Mulligan DC, Gish RG, Krowka MJ. Fallon MB, et al. Among authors: krowka mj. Liver Transpl. 2006 Dec;12(12 Suppl 3):S105-7. doi: 10.1002/lt.20971. Liver Transpl. 2006. PMID: 17123282 Free article. No abstract available.

10

Model for end-stage liver disease (MELD) exception for portopulmonary hypertension.

Krowka MJ, Fallon MB, Mulligan DC, Gish RG. Krowka MJ, et al. Liver Transpl. 2006 Dec;12(12 Suppl 3):S114-6. doi: 10.1002/lt.20975. Liver Transpl. 2006. PMID: 17123283 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

196 results

Search Page

Filters